Missed the AAP's new pediatric UTI guideline? This easy-to-read FAQ covers the key changes in diagnosis, treatment, imaging, and prevention.
|Articles|December 1, 2012
Kawasaki disease
Some recent studies show the significant effects of Kawasaki disease on coronary arteries. Researchers all agree on the urgent need for early diagnosis and improved treatment therapies.
Advertisement
Advertisement
Related to this article
Christina Boull, MD, explains how pediatricians can recognize dermatologic conditions in darker skin tones and address pigment changes and treatment gaps.
Tezepelumab produced histologic remission in up to 68.9% of patients aged 12+ with EoE vs 3.5% with placebo at week 24, sustained to week 52.
Black race was the strongest predictor of T2-high inflammation in 451 children with severe asthma adjusted for social and environmental factors.
Researchers discuss how testosterone changes during early puberty may influence depression and anxiety symptoms in girls and implications for pediatricians.
A Mott Poll of 2,027 parents found 81% say having a baby costs too much; 73% strongly back state paid leave around birth.
In phase 3 SHINE-2, 50% of mirikizumab induction responders aged 6 to 17 with moderate to severe UC were in clinical remission at week 52.
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Testosterone changes linked to emotional distress in pubertal girls
2
Tezepelumab sustains EoE remission through 52 weeks
3
Recognizing skin conditions in children with darker skin tones
4
Mirikizumab meets 1-year remission end point in pediatric UC
5